# Microneedling and Latanoprost in Acrofacial Vitiligo

> **NCT03611348** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Sohag University** · enrollment: 70 (estimated)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** Latanoprost
- **DEVICE:** Microneedling

## Key facts

- **NCT ID:** NCT03611348
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2019-09-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2018-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03611348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03611348, "Microneedling and Latanoprost in Acrofacial Vitiligo". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03611348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*